Eight from MIT named 2024 Sloan Research Fellows
Fellows honored for creativity, innovation, and research accomplishments.
Fellows honored for creativity, innovation, and research accomplishments.
Jonathan Weissman and collaborators developed a tool to reconstruct human cell family trees, revealing how blood cell production changes in old age.
Using a DNA-based scaffold carrying viral proteins, researchers created a vaccine that provokes a strong antibody response against SARS-CoV-2.
Twelve researchers selected as finalists for 2023-24 MIT-Royalty Pharma Prize Competition to support female entrepreneurs in biotech.
The advance makes it easier to detect circulating tumor DNA in blood samples, which could enable earlier cancer diagnosis and help guide treatment.
MIT researchers can now track a cell’s RNA expression to investigate long-term processes like cancer progression or embryonic development.
MIT Koch Institute researchers Daniel Anderson and Ana Jaklenec, plus 11 MIT alumni, are honored for inventions that have made a tangible impact on society.
These compounds can kill methicillin-resistant Staphylococcus aureus (MRSA), a bacterium that causes deadly infections.
Researchers are working to advance the field of glycoscience, illuminating the essential role of carbohydrates for human health and disease.
By analyzing bacterial data, researchers have discovered thousands of rare new CRISPR systems that have a range of functions and could enable gene editing, diagnostics, and more.
First-year MIT student and former Time “Kid of the Year” honored for promoting science and innovation among youth and inspiring them with several inventions.
BRAIN CONNECTS supports McGovern Institute and Department of Brain and Cognitive Sciences research aimed at mapping the brain’s connections.
MIT computer scientists developed a way to calculate polygenic scores that makes them more accurate for people across diverse ancestries.
Five MIT faculty, along with seven additional affiliates, are honored for outstanding contributions to medical research.
By focusing on causal relationships in genome regulation, a new AI method could help scientists identify new immunotherapy techniques or regenerative therapies.